ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Linalool exerts antiemetic effects via dopaminergic and serotonergic pathways: Evidence from chick model and molecular docking.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Linalool (LIN), a naturally occurring monoterpene alcohol found in aromatic plants, exhibits diverse pharmacological properties, yet its antiemetic potential remains underexplored. In this study, we investigated the antiemetic efficacy of LIN using both in vivo and in silico approaches. Emesis was induced in chicks via oral administration of copper sulfate pentahydrate (50 mg/kg), and LIN was tested at doses of 25, 50, and 100 mg/kg. Its effects were compared against the standard antiemetics domperidone (DOM, 7 mg/kg) and ondansetron (OND, 5 mg/kg). Results demonstrated that LIN at 100 mg/kg significantly prolonged the emetic latency and reduced the number of retches. Notably, co-administration of LIN (50 mg/kg) with DOM significantly (p < 0.05) produced the most potent effect, yielding the highest latency and lowest number of retches, reflecting a synergistic interaction. Molecular docking studies revealed a strong binding affinity of LIN to the dopamine D2 receptor (- 6.4 kcal/mol) and moderate binding to the 5-HT3 receptor (- 5.3 kcal/mol), suggesting involvement of both dopaminergic and serotonergic mechanisms. These findings collectively indicate that LIN possesses significant antiemetic activity and may offer a plant-derived alternative for emesis control.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.